The For The Media website offers news releases for upcoming studies from The JAMA Network journals, PDFs of embargoed studies, and the weekly JAMA Report video.
LEARN MORE: About The JAMA Network Journals | For the Media FAQs

New from the JAMA Report

use this as template for single videos
Read the Video Script
Print

A COMBINATION OF MEDICATIONS MORE EFFECTIVE FOR OLDER PATIENTS WITH C-O-P-D

INTRO: Chronic obstructive pulmonary disease, or C-O-P-D, is the third leading cause of death worldwide. Medications are the mainstay of C-O-P-D management. A new study examined two different regimens and how these medications might impact older people who have C-O-P-D. Catherine Dolf explains in this week’s JAMA Report.

VIDEO
B-ROLL
X-ray of patient with COPD, various COPD medications

AUDIO
VO
PATIENTS WITH C-O-P-D NOT ONLY HAVE A DIFFICULT TIME BREATHING BUT IF THE DISEASE IS NOT MANAGED WITH EFFECTIVE MEDICATIONS, THERE CAN BE OTHER HEALTH PROBLEMS.

AUDIO
SOT/FULL Super@:08 Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:09
“It’s not a disease that just affects their lungs. It affects their body they can end up losing a lot of weight and become very weak. They can get osteoporosis and other types of diseases.”

(Video covering 2nd part of bite: people walking on street)

VIDEO
B-ROLL
Dr. Gershon walking down hall, looking at patient files, walks in room and looks at x-rays, pointing at x-ray

AUDIO
VO
DR. ANDREA GERSHON FROM THE SUNNYBROOK HEALTH SCIENCES CENTRE AND CO-AUTHORS STUDIED DATA FROM ALL ACROSS ONTARIO, CANADA, INVOLVING PATIENTS 66 AND OLDER WITH C-O-P-D. PATIENTS WERE NEWLY INTRODUCED TO TWO MEDICATION REGIMENS. THE TWO REGIMENS WERE THEN COMPARED TO FIND OUT WHICH WAS MORE EFFECTIVE AT PREVENTING C-O-P-D RELATED HOSPITALIZATIONS AND DEATH. THE PATIENTS WERE FOLLOWED UNTIL THEY WERE HOSPITALIZED, DIED OR UNTIL THE END OF THE SEVEN YEAR STUDY PERIOD.

AUDIO
SOT/FULL Super@:42
Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:13
“The first group we looked at was people who were on a long-acting beta-agonist, we call them LABA’s for short and we compared them to people who started a long-acting beta-agonist and inhaled corticosteroid.”

(Video covering end of bite: COPD medication)

VIDEO
B-ROLL
Graphic showing airways narrowing and inflamed

AUDIO
VO
LABA’s HELP OPEN THE NARROWED AIRWAYS AND INHALED CORTICOSTEROIDS WORK TO DECREASE INFLAMMATION IN THOSE AIRWAYS.

AUDIO
SOT/FULL Super@ 1:04 Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:10
“If they’re on the combination therapies opposed to the one medication alone they’re actually going to do better, they’re actually going to stay out of hospital and they’re actually going to live longer.”

GXF FULL
JAMA COVER

AUDIO
VO
THE STUDY APPEARS IN JAMA, JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

AUDIO
SOT/FULL Super@ 1:15 Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:07
“There were no increase in side effects, specifically pneumonia and osteoporosis that we observed.”

VIDEO
B-ROLL
Dr. Gershon talking to patient

AUDIO
VO
THE STUDY ALSO INCLUDED PEOPLE WHO HAD A DIAGNOSIS OF BOTH ASTHMA AND C-O-P-D.

AUDIO
SOT/FULL Super@ 1:26 Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:09
“The incremental benefit of the combination therapy over the LABA alone seemed greater in people with a co-diagnosis of asthma than without asthma.”

(Video covering end of bite: Dr. Gershon talking with patient)

VIDEO
B-ROLL
Various shots of Dr. Gershon listening to patient breathe

AUDIO
VO
THE COMBINATION THERAPY WAS ALSO MORE EFFECTIVE WHEN PATIENTS WERE NOT ALREADY TAKING A LONG-ACTING ANTICHOLINERGIC, ANOTHER VERY COMMONLY USED C-O-P-D MEDICATION.

AUDIO
SOT/FULL Super@1:52 Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:14
“I think even as physicians we prefer that patients be on less medication but in this situation, we have an opportunity for patients to have a discussion with their doctors and determine what’s best for them.”

(Video covering 1st of bite: Several COPD medications, Dr. Gershon and patient talking)

VIDEO
B-ROLL
Dr. Gershon on camera

AUDIO
VO
CATHERINE DOLF, THE JAMA REPORT.

TAG: STUDY AUTHORS SAY THESE FINDINGS NEED TO BE CONFIRMED IN OTHER STUDIES AND CLINICAL TRIALS.

INTRO: Chronic obstructive pulmonary disease, or C-O-P-D, is the third leading cause of death worldwide. Medications are the mainstay of C-O-P-D management. A new study examined two different regimens and how these medications might impact older people who have C-O-P-D. Catherine Dolf explains in this week’s JAMA Report.

VIDEO
B-ROLL
X-ray of patient with COPD, various COPD medications

AUDIO
VO
PATIENTS WITH C-O-P-D NOT ONLY HAVE A DIFFICULT TIME BREATHING BUT IF THE DISEASE IS NOT MANAGED WITH EFFECTIVE MEDICATIONS, THERE CAN BE OTHER HEALTH PROBLEMS.

AUDIO
SOT/FULL Super@:08 Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:09
“It’s not a disease that just affects their lungs. It affects their body they can end up losing a lot of weight and become very weak. They can get osteoporosis and other types of diseases.”

(Video covering 2nd part of bite: people walking on street)

VIDEO
B-ROLL
Dr. Gershon walking down hall, looking at patient files, walks in room and looks at x-rays, pointing at x-ray

AUDIO
VO
DR. ANDREA GERSHON FROM THE SUNNYBROOK HEALTH SCIENCES CENTRE AND CO-AUTHORS STUDIED DATA FROM ALL ACROSS ONTARIO, CANADA, INVOLVING PATIENTS 66 AND OLDER WITH C-O-P-D. PATIENTS WERE NEWLY INTRODUCED TO TWO MEDICATION REGIMENS. THE TWO REGIMENS WERE THEN COMPARED TO FIND OUT WHICH WAS MORE EFFECTIVE AT PREVENTING C-O-P-D RELATED HOSPITALIZATIONS AND DEATH. THE PATIENTS WERE FOLLOWED UNTIL THEY WERE HOSPITALIZED, DIED OR UNTIL THE END OF THE SEVEN YEAR STUDY PERIOD.

AUDIO
SOT/FULL Super@:42
Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:13
“The first group we looked at was people who were on a long-acting beta-agonist, we call them LABA’s for short and we compared them to people who started a long-acting beta-agonist and inhaled corticosteroid.”

(Video covering end of bite: COPD medication)

VIDEO
B-ROLL
Graphic showing airways narrowing and inflamed

AUDIO
VO
LABA’s HELP OPEN THE NARROWED AIRWAYS AND INHALED CORTICOSTEROIDS WORK TO DECREASE INFLAMMATION IN THOSE AIRWAYS.

AUDIO
SOT/FULL Super@ 1:04 Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:10
“If they’re on the combination therapies opposed to the one medication alone they’re actually going to do better, they’re actually going to stay out of hospital and they’re actually going to live longer.”

GXF FULL
JAMA COVER

AUDIO
VO
THE STUDY APPEARS IN JAMA, JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION.

AUDIO
SOT/FULL Super@ 1:15 Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:07
“There were no increase in side effects, specifically pneumonia and osteoporosis that we observed.”

VIDEO
B-ROLL
Dr. Gershon talking to patient

AUDIO
VO
THE STUDY ALSO INCLUDED PEOPLE WHO HAD A DIAGNOSIS OF BOTH ASTHMA AND C-O-P-D.

AUDIO
SOT/FULL Super@ 1:26 Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:09
“The incremental benefit of the combination therapy over the LABA alone seemed greater in people with a co-diagnosis of asthma than without asthma.”

(Video covering end of bite: Dr. Gershon talking with patient)

VIDEO
B-ROLL
Various shots of Dr. Gershon listening to patient breathe

AUDIO
VO
THE COMBINATION THERAPY WAS ALSO MORE EFFECTIVE WHEN PATIENTS WERE NOT ALREADY TAKING A LONG-ACTING ANTICHOLINERGIC, ANOTHER VERY COMMONLY USED C-O-P-D MEDICATION.

AUDIO
SOT/FULL Super@1:52 Andrea S. Gershon, M.D., M.Sc., – Sunnybrook Health Sciences Centre Runs:14
“I think even as physicians we prefer that patients be on less medication but in this situation, we have an opportunity for patients to have a discussion with their doctors and determine what’s best for them.”

(Video covering 1st of bite: Several COPD medications, Dr. Gershon and patient talking)

VIDEO
B-ROLL
Dr. Gershon on camera

AUDIO
VO
CATHERINE DOLF, THE JAMA REPORT.

TAG: STUDY AUTHORS SAY THESE FINDINGS NEED TO BE CONFIRMED IN OTHER STUDIES AND CLINICAL TRIALS.

Recent News Releases

News releases are made freely available to the general public. View all Past Releases >

JAMA Ophthalmology

Releases For September 18, 2014

JAMA Otolaryngology–Head & Neck Surgery

Releases For September 18, 2014